Interpretation of Antibiotic Trials in Pediatric Pneumonia
Susan C Lipsett1,2, Alexander W Hirsch1,2, Richard G Bachur1,2
1Division of Emergency Medicine, Boston Children's Hospital, Boston, Massachusetts.
JAMA Network Open
|February 2, 2024
Abstract
No abstract available in PubMed .
More Related Videos
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
7.0K
07:46Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
Published on: June 5, 2012
33.0K
Related Concept Videos
01:30Pneumonia III: Complications and Assessment
225
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
225
01:28Pneumonia IV: Management
329
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
329